Rafferty Asset Management, LLC Avidity Biosciences, Inc. Transaction History

Rafferty Asset Management, LLC

$29.7 Billion
Q3 2025

A detailed history of Rafferty Asset Management, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 173,480 shares of RNA stock, worth $12.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

173,480

Previous 126,882 36.73%

Holding current value

$12.3 Million

Previous $3.6 Million 109.77%

% of portfolio

0.03%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$28.46 - $50.36 $1.33 Million - $2.35 Million	46,598 Added 36.73%	173,480 $7.56 Million
Q2 2025 Aug 14, 2025	SELL	$24.08 - $36.24 $431,874 - $649,964	-17,935 Reduced 12.38%	126,882 $3.6 Million
Q1 2025 May 14, 2025	SELL	$27.05 - $35.11 $870,117 - $1.13 Million	-32,167 Reduced 18.18%	144,817 $4.27 Million
Q4 2024 Feb 14, 2025	SELL	$29.08 - $52.5 $650,839 - $1.18 Million	-22,381 Reduced 11.23%	176,984 $5.15 Million
Q3 2024 Nov 13, 2024	BUY	$37.21 - $48.14 $2.93 Million - $3.79 Million	78,808 Added 65.37%	199,365 $9.16 Million
Q2 2024 Aug 13, 2024	SELL	$22.73 - $40.85 $3.33 Million - $5.99 Million	-146,575 Reduced 54.87%	120,557 $4.92 Million
Q1 2024 May 13, 2024	SELL	$9.16 - $25.52 $27,727 - $77,249	-3,027 Reduced 1.12%	267,132 $6.82 Million
Q4 2023 Feb 13, 2024	SELL	$4.87 - $9.37 $579,155 - $1.11 Million	-118,923 Reduced 30.57%	270,159 $2.44 Million
Q3 2023 Nov 13, 2023	SELL	$6.3 - $11.35 $1.38 Million - $2.48 Million	-218,428 Reduced 35.95%	389,082 $2.48 Million
Q2 2023 Aug 11, 2023	BUY	$10.62 - $17.34 $2.41 Million - $3.93 Million	226,589 Added 59.48%	607,510 $6.74 Million
Q1 2023 May 11, 2023	BUY	$15.35 - $25.65 $982,062 - $1.64 Million	63,978 Added 20.19%	380,921 $5.85 Million
Q4 2022 Feb 13, 2023	BUY	$10.06 - $22.66 $1.83 Million - $4.12 Million	181,861 Added 134.63%	316,943 $7.03 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $1.39 Million - $2.11 Million	90,108 Added 200.36%	135,082 $2.21 Million
Q2 2022 Aug 12, 2022	SELL	$11.18 - $20.5 $367,296 - $673,486	-32,853 Reduced 42.21%	44,974 $653,000
Q1 2022 May 13, 2022	BUY	$14.2 - $23.78 $193,404 - $323,883	13,620 Added 21.21%	77,827 $1.44 Million
Q4 2021 Feb 10, 2022	BUY	$20.4 - $28.66 $463,610 - $651,327	22,726 Added 54.79%	64,207 $1.53 Million
Q3 2021 Nov 10, 2021	SELL	$18.16 - $25.21 $121,944 - $169,285	-6,715 Reduced 13.93%	41,481 $1.02 Million
Q2 2021 Aug 10, 2021	SELL	$19.62 - $29.26 $245,406 - $365,984	-12,508 Reduced 20.6%	48,196 $1.19 Million
Q1 2021 May 10, 2021	BUY	$20.28 - $28.15 $1.23 Million - $1.71 Million	60,704 New	60,704 $1.32 Million

Others Institutions Holding RNA

# of Institutions

311

Shares Held

139M

Call Options Held

1.24M

Put Options Held

531K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $3.69B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Avidity Biosciences, Inc. Transaction History